Rob Macrae, MD, FRCPC | Authors

Irinotecan and Radiation in Combined-Modality Therapy for Solid Tumors

July 01, 2001

Irinotecan (CPT-11, Camptosar) is a camptothecin derivative thatis thought to exert its cytotoxic effects by targeting topoisomerase

Irinotecan in Combined-Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer

January 01, 2001

The management of non-small-cell lung cancer is undergoing rapid evolution. Although the advent of combined-modality therapy has led to improved survival, most patients eventually succumb to the disease. The arrival of a